Health Economics and Genomics: What Do We Know and What Remains To Be Done?

Unravelling the human genome is one of the most remarkable achievements of our generation. This seminar will answer questions about the scope of the impact of genomic medicine and how it fits with our economic and the policy environment. It will report on our findings of cost effectiveness of the use of genomic testing and the scale of the impacts of genetic conditions on the social and economic prospects of families. It will also address questions such as:

  • Where will the health benefits first come from?
  • Is our policy environment ready for genomics?
  • What type of costs and savings can be anticipate in the future?
  • Which government portfolios will be most impacted?
  • Measuring costs and benefits.

About the speaker
Professor Schofield is Director of GenIMPACT: Centre for Economic Impacts of Genomic Medicine and Professor and Chair of Health Economics in the Macquarie Business School, Macquarie University. She also has honorary appointments with the Garvan Institute of Medical Research and the University of Sydney.

Her career has spanned the Australian Government public service, academia and clinical practice and she has a national and international reputation for her work in economic modelling of the health system.

She currently runs a research program on economics and genomics and the productivity impacts of health.